Cardiac ischemia-reperfusion regulates sympathetic neuropeptide expression through gp130-dependent and independent mechanisms

Neuropeptides

Volumn 45, Issue 1, 2011, Pages 33-42

  Alston, Eric N ^a   Parrish, Diana C ^a   Hasan, Wohaib ^a   Tharp, Kevin ^a   Pahlmeyer, Laura ^a   Habecker, Beth A ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Galanin; Neuropeptide Y; Pituitary adenylate cyclase activating peptides; Vasoactive intestinal peptide

Indexed keywords

GALANIN; GLYCOPROTEIN GP 130; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; MESSENGER RNA; NEUROPEPTIDE Y; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENOTYPE; HEART; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MOUSE; NERVE FIBER; NERVE FIBER REGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STELLATE GANGLION; SYMPATHETIC NERVE CELL;

ANIMALS; CYTOKINE RECEPTOR GP130; GALANIN; HEART; HUMANS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIAL ISCHEMIA; MYOCARDIUM; NEUROPEPTIDE Y; NEUROPEPTIDES; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; REPERFUSION INJURY; SYMPATHETIC NERVOUS SYSTEM; VASOACTIVE INTESTINAL PEPTIDE;

MUS;

EID: 78650764631     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.npep.2010.10.002     Document Type: Article

References (68)

1. Allen J.M., Bircham P.M.M., Edwards A.V., Tatemoto K., Bloom S.R. Neuropeptide Y (NPY) reduces myocardial perfusion and inhibits the force of contraction of the isolated perfused rabbit heart. Regulatory Peptides 1983, 6:247-253.
2. Anderson F.L., Port J.D., Reid B.B., Larrabee P., Hanson G., Bristow M.R. Myocardial catecholamine and neuropeptide Y depletion in failing ventricles of patients with idiopathic dilated cardiomyopathy. Correlation with beta-adrenergic receptor downregulation. Circulation 1992, 85:46-53.
3. Aoyama T., Takimoto Y., Pennica D., Inoue R., Shinoda E., Hattori R., Yui Y., Sasayama S. Augmented expression of cardiotrophin-1 and its receptor component, gp130, in both left and right ventricles after myocardial infarction in the rat. Journal of Molecular and Cellular Cardiology 2000, 32:1821-1830.
4. Beaudet M.M., Parsons R.L., Braas K.M., May V. Mechanisms mediating pituitary adenylate cyclase-activating polypeptide depolarization of rat sympathetic neurons. Journal of Neuroscience 2000, 20:7353-7361.
5. Bergner A.J., Murphy S.M., Anderson C.R. After axotomy, substance P and vasoactive intestinal peptide expression occurs in pilomotor neurons in the rat superior cervical ganglion. Neuroscience 2000, 96:611-618.
6. Boeshore K.L., Schreiber R.C., Vaccariello S.A., Sachs H.H., Salazar R., Lee J., Ratan R.R., Leahy P., Zigmond R.E. Novel changes in gene expression following axotomy of a sympathetic ganglion: a microarray analysis. Journal of Neurobiology 2004, 59:216-235.
7. Braas K.M., May V. Pituitary adenylate cyclase-activating polypeptides directly stimulate sympathetic neuron neuropeptide Y release through PAC(1) receptor isoform activation of specific intracellular signaling pathways. Journal of Biological Chemistry 1999, 274:27702-27710.
8. Brar B.K., Stephanou A., Liao Z., O'Leary R.M., Pennica D., Yellon D.M., Latchman D.S. Cardiotrophin-1 can protect cardiac myocytes from injury when added both prior to simulated ischaemia and at reoxygenation. Cardiovascular Research 2001, 51:265-274.
9. Bruch L., Bychkov R., Kastner A., Bulow T., Ried C., Gollasch M., Baumann G., Luft F.C., Haller H. Pituitary adenylate-cyclase-activating peptides relax human coronary arteries by activating K(ATP) and K(Ca) channels in smooth muscle cells. Journal Vascular Research 1997, 34:11-18.
10. Dalsgaard T., Hannibal J., Fahrenkrug J., Larsen C.R., Ottesen B. VIP and PACAP display different vasodilatory effects in rabbit coronary and cerebral arteries. Regulatory Peptides 2003, 110:179-188.
11. Esler M. The autonomic nervous system and cardiac arrhythmias. Clinical Autonomic Research 1992, 2:133-135.
12. Ewert T.J., Gritman K.R., Bader M., Habecker B.A. Post-infarct cardiac sympathetic hyperactivity regulates galanin expression. Neuroscience Letters 2008, 436:163-166.
13. Frangogiannis N.G., Smith C.W., Entman M.L. The inflammatory response in myocardial infarction. Cardiovascular Research 2002, 53:31-47.
14. Gasz B., Racz B., Roth E., Borsiczky B., Ferencz A., Tamas A., Cserepes B., Lubics A., Gallyas F., Toth G., Lengvari I., Reglodi D. Pituitary adenylate cyclase activating polypeptide protects cardiomyocytes against oxidative stress-induced apoptosis. Peptides 2006, 27:87-94.
15. Gasz B., Racz B., Roth E., Borsiczky B., Tamas A., Boronkai A., Gallyas F., Toth G., Reglodi D. PACAP inhibits oxidative stress-induced activation of MAP kinase-dependent apoptotic pathway in cultured cardiomyocytes. Annals of the New York Academy of Sciences 2006, 1070:293-297.
16. Girard B.M., May V., Bora S.H., Fina F., Braas K.M. Regulation of neurotrophic peptide expression in sympathetic neurons: quantitative analysis using radioimmunoassay and real-time quantitative polymerase chain reaction. Regulatory Peptides 2002, 109:89-101.
17. Graham L.N., Smith P.A., Huggett R.J., Stoker J.B., Mackintosh A.F., Mary D.A. Sympathetic drive in anterior and inferior uncomplicated acute myocardial infarction. Circulation 2004, 109:2285-2289.
18. Graham L.N., Smith P.A., Stoker J.B., Mackintosh A.F., Mary D.A. Time course of sympathetic neural hyperactivity after uncomplicated acute myocardial infarction. Circulation 2002, 106:793-797.
19. Gritman K., Van Winkle D.M., Lorentz C.U., Pennica D., Habecker B.A. The lack of cardiotrophin-1 alters expression of interleukin-6 and leukemia inhibitory factor mRNA but does not impair cardiac injury response. Cytokine 2006, 36:9-16.
20. Gwechenberger M., Mendoza L.H., Youker K.A., Frangogiannis N.G., Smith C.W., Michael L.H., Entman M.L. Cardiac myocytes produce interleukin-6 in culture and in viable border zone of reperfused infarctions. Circulation 1999, 99:546-551.
21. Habecker B.A., Gritman K.R., Willison B.D., Van Winkle D.M. Myocardial infarction stimulates galanin expression in cardiac sympathetic neurons. Neuropeptides 2005, 39:89-95.
22. Habecker B.A., Sachs H.H., Rohrer H., Zigmond R.E. The dependence on gp130 cytokines of axotomy induced neuropeptide expression in adult sympathetic neurons. Developmental Neurobiology 2009, 69:392-400.
23. Heinrich P.C., Behrmann I., Müller-Newen G., Schaper F., Graeve L. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochemical Journal 1998, 334:297-314.
24. Henning R.J., Sawmiller D.R. Vasoactive intestinal peptide: cardiovascular effects. Cardiovascular Research 2001, 49:27-37.
25. Herring N., Lokale M.N., Danson E.J., Heaton D.A., Paterson D.J. Neuropeptide Y reduces acetylcholine release and vagal bradycardia via a Y2 receptor-mediated, protein kinase C-dependent pathway. Journal of Molecular and Cellular Cardiology 2008, 44:477-485.
26. Hirota H., Chen J., Betz U.A., Rajewsky K., Gu Y., Ross J., Muller W., Chien K.R. Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress. Cell 1999, 97:189-198.
27. Holmes F.E., Mahoney S., King V.R., Bacon A., Kerr N.C., Pachnis V., Curtis R., Priestley J.V., Wynick D. Targeted disruption of the galanin gene reduces the number of sensory neurons and their regenerative capacity. Proceedings of the National Academy of Science (US) 2000, A97:11563-11568.
28. Hyatt Sachs H., Rohrer H., Zigmond R.E. The conditioning lesion effect on sympathetic neurite outgrowth is dependent on gp130 cytokines. Experimental Neurology 2010, 223:516-522.
29. Hyatt-Sachs H., Schreiber R.C., Bennett T.A., Zigmond R.E. Phenotypic plasticity in adult sympathetic ganglia in vivo: effects of deafferentation and axotomy on the expression of vasoactive intestinal peptide. Journal of Neuroscience 1993, 13:1642-1653.
30. Ji R.R., Zhang X., Zhang Q., Dagerlind A., Nilsson S., Wiesenfeld-Hallin Z., Hokfelt T. Central and peripheral expression of galanin in response to inflammation. Neuroscience 1995, 68:563-576.
31. Karlsberg R.P., Penkoske P.A., Cryer P.E., Corr P.B., Roberts R. Rapid activation of the sympathetic nervous system following coronary artery occlusion: relationship to infarct size, site, and hemodynamic impact. Cardiovascular Research 1979, 13:523-531.
32. Kastner A., Bruch L., Will-Shahab L., Modersohn D., Baumann G. Pituitary adenylate cyclase activating peptides are endothelium-independent dilators of human and porcine coronary arteries. Agents and Actions Supplements 1995, 45:283-289.
33. Klimaschewski L., Tran T.D., Nobiling R., Heym C. Plasticity of postganglionic sympathetic neurons in the rat superior cervical ganglion after axotomy. Microscopy Research and Technique 1994, 29:120-130.
34. Kolakowski L.F., Neill G.P., Howard A.D., Broussard S.R., Sullivan K.A., Feighner S.D., Sawzdargo M., Nguyen T., Kargman S., Shiao L.L., Hreniuk D.L., Tan C.P., Evans J., Abramovitz M., Chateauneuf A., Coulombe N., Ng G., Johnson M.P., Tharian A., Khoshbouei H., George S.R., Smith R.G., Dowd B.F. Molecular characterization and expression of cloned human galanin receptors GALR2 and GALR3. Journal of Neurochemistry 1998, 71:2239-2251.
35. La Rovere M.T., Bigger J.T., Marcus F.I., Mortara A., Schwartz P.J. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. Autonomic tone and reflexes after myocardial infarction investigators. Lancet 1998, 351:478-484.
36. La Rovere M.T., Pinna G.D., Hohnloser S.H., Marcus F.I., Mortara A., Nohara R., Bigger J.T., Camm A.J., Schwartz P.J. Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: implications for clinical trials. Circulation 2001, 103:2072-2077.
37. Lewis S.E., Rao M.S., Symes A.J., Dauer W.T., Fink J.S., Landis S.C., Hyman S.E. Coordinate regulation of choline acetyltransferase, tyrosine hydroxylase, and neuropeptide mRNAs by ciliary neurotrophic factor and leukemia inhibitory factor in cultured sympathetic neurons. Journal of Neurochemistry 1994, 63:429-438.
38. Lopez-Sendon J., Swedberg K., McMurray J., Tamargo J., Maggioni A.P., Dargie H., Tendera M., Waagstein F., Kjekshus J., Lechat P., Torp-Pedersen C. Expert consensus document on beta-adrenergic receptor blockers. European Heart Journal 2004, 25:1341-1362.
39. Lorentz C.U., Alston E.N., Belcik J.T., Lindner J.R., Giraud G.D., Habecker B.A. Heterogeneous ventricular sympathetic innervation, altered beta adrenergic receptor expression, and rhythm instability in mice lacking p75 neurotrophin receptor. American Journal of Physiology Heart and Circulatory Physiology 2010, 298:H1652-H1660.
40. Love S., Nyquist-Battie C., DiMaggio D.A., Farah J.M., Chronwall B.M. Diminished neuropeptide Y and dopamine beta-hydroxylase immunoreactivity in a guinea pig model of left ventricular hypertrophy. Cardiovascular Research 1993, 27:494-499.
41. Mahoney S.A., Hosking R., Farrant S., Holmes F.E., Jacoby A.S., Shine J., Iismaa T.P., Scott M.K., Schmidt R., Wynick D. The second galanin receptor GalR2 plays a key role in neurite outgrowth from adult sensory neurons. Journal of Neuroscience 2003, 23:416-421.
42. Mori H., Nakamachi T., Ohtaki H., Yofu S., Sato A., Endo K., Iso Y., Suzuki H., Takeyama Y., Shintani N., Hashimoto H., Baba A., Shioda S. Cardioprotective effect of endogenous pituitary adenylate cyclase-activating polypeptide on Doxorubicin-induced cardiomyopathy in mice. Circulation Journal 2010, 74:1183-1190.
43. Nolan J., Batin P.D., Andrews R., Lindsay S.J., Brooksby P., Mullen M., Baig W., Flapan A.D., Cowley A., Prescott R.J., Neilson J.M., Fox K.A. Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart). Circulation 1998, 98:1510-1516.
44. Omland T., Opstad K., Dickstein K. Plasma neuropeptide Y levels in the acute and early convalescent phase after myocardial infarction. American Heart Journal 1994, 127:774-779.
45. Parrish D.C., Alston E.N., Rohrer H., Nkadi P., Woodward W.R., Schutz G., Habecker B.A. Infarction-induced cytokines cause local depletion of tyrosine hydroxylase in cardiac sympathetic nerves. Experimental Physiology 2009, 95:304-314.
46. Pirola F.T., Potter E.K. Vagal action on atrioventricular conduction and its inhibition by sympathetic stimulation and neuropeptide Y in anaesthetised dogs. Journal of the Autonomic Nervous System 1990, 31:1-12.
47. Potter E.K., Smith-White M.A. Galanin modulates cholinergic neurotransmission in the heart. Neuropeptides 2005, 39:345-348.
48. Racz B., Gasz B., Gallyas F., Kiss P., Tamas A., Szanto Z., Lubics A., Lengvari I., Toth G., Hegyi O., Roth E., Reglodi D. PKA-Bad-14-3-3 and Akt-Bad-14-3-3 signaling pathways are involved in the protective effects of PACAP against ischemia/reperfusion-induced cardiomyocyte apoptosis. Regulatory Peptides 2008, 145:105-115.
49. Rao M.S., Landis S.C. Characterization of a target-derived neuronal cholinergic differentiation factor. Neuron 1990, 5:899-910.
50. Rao M.S., Sun Y., Escary J.L., Perreau J., Tresser S., Patterson P.H., Zigmond R.E., Brulet P., Landis S.C. Leukemia inhibitory factor mediates an injury response but not a target-directed developmental transmitter switch in sympathetic neurons. Neuron 1993, 11:1175-1185.
51. Rao M.S., Tyrrell S., Landis S.C., Patterson P.H. Effects of ciliary neurotrophic factor (CNTF) and depolarization on neuropeptide expression in cultured sympathetic neurons. Developmental Biology 1992, 150:281-293.
52. Roth E., Weber G., Kiss P., Horvath G., Toth G., Gasz B., Ferencz A., Gallyas F., Reglodi D., Racz B. Effects of PACAP and preconditioning against ischemia/reperfusion-induced cardiomyocyte apoptosis in vitro. Annals of the New York Academy of Sciences 2009, 1163:512-516.
53. Roudenok V., Gutjar L., Antipova V., Rogov Y. Expression of vasoactive intestinal polypeptide and calcitonin gene-related peptide in human stellate ganglia after acute myocardial infarction. Annals of Anatomy 2001, 183:341-344.
54. Sano H., Miyata A., Horio T., Nishikimi T., Matsuo H., Kangawa K. The effect of pituitary adenylate cyclase activating polypeptide on cultured rat cardiocytes as a cardioprotective factor. Regulatory Peptides 2002, 109:107-113.
55. Schreiber R.C., Hyatt-Sachs H., Bennett T.A., Zigmond R.E. Galanin expression increases in adult rat sympathetic neurons after axotomy. Neuroscience 1994, 60:17-27.
56. Schwartz P.J. The autonomic nervous system and sudden death. European Heart Journal 1998, 19(Suppl. F):F72-F80.
57. Shadiack A.M., Zigmond R.E. Galanin induced in sympathetic neurons after axotomy is anterogradely transported toward regenerating nerve endings. Neuropeptides 1998, 32:257-264.
58. Shakiryanova D., Tully A., Hewes R.S., Deitcher D.L., Levitan E.S. Activity-dependent liberation of synaptic neuropeptide vesicles. Nature Neuroscience 2005, 8:173-178.
59. Smith-White M.A., Iismaa T.P., Potter E.K. Galanin and neuropeptide Y reduce cholinergic transmission in the heart of the anaesthetised mouse. British Journal of Pharmacology 2003, 140:170-178.
60. Stanke M., Duong C.V., Pape M., Geissen M., Burbach G., Deller T., Gascan H., Otto C., Parlato R., Schutz G., Rohrer H. Target-dependent specification of the neurotransmitter phenotype: cholinergic differentiation of sympathetic neurons is mediated in vivo by gp130 signaling. Development 2006, 133:141-150.
61. Suarez V., Guntinas-Lichius O., Streppel M., Ingorokva S., Grosheva M., Neiss W.F., Angelov D.N., Klimaschewski L. The axotomy-induced neuropeptides galanin and pituitary adenylate cyclase-activating peptide promote axonal sprouting of primary afferent and cranial motor neurones. European Journal of Neuroscience 2006, 24:1555-1564.
62. Sullivan K.A., Shiao L.L., Cascieri M.A. Pharmacological characterization and tissue distribution of the human and rat GALR1 receptors. Biochemical and Biophysical Research Communications 1997, 233:823-828.
63. Tyrrell S., Landis S.C. The appearance of NPY and VIP in sympathetic neuroblasts and subsequent alterations in their expression. Journal of Neuroscience 1994, 14:4529-4547.
64. Ulman L.G., Potter E.K., McCloskey D.I. Effects of sympathetic activity and galanin on cardiac vagal action in anaesthetized cats. Journal of Physiology 1992, 448:225-235.
65. Wang S., He C., Maguire M.T., Clemmons A.L., Burrier R.E., Guzzi M.F., Strader C.D., Parker E.M., Bayne M.L. Genomic organization and functional characterization of the mouse GalR1 galanin receptor. Federation of European Biochemical Society Letters 1997, 411:225-230.
66. Yoshida K., Taga T., Saito M., Suematsu S., Kumanogoh A., Tanaka T., Fujiwara H., Hirata M., Yamagami T., Nakahata T., Hirabayashi T., Yoneda Y., Tanaka K., Wang W.Z., Mori C., Shiota K., Yoshida N., Kishimoto T. Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders. Proceedings of the National Academy of Science (US) 1996, 93:407-411.
67. Zigmond R.E., Hyatt-Sachs H., Mohney R.P., Schreiber R.C., Shadiack A.M., Sun Y., Vaccariello S.A. Changes in neuropeptide phenotype after axotomy of adult peripheral neurons and the role of leukemia inhibitory factor. Perspectives on Developmental Neurobiology 1996, 4:75-90.
68. Zou Y., Takano H., Mizukami M., Akazawa H., Qin Y., Toko H., Sakamoto M., Minamino T., Nagai T., Komuro I. Leukemia inhibitory factor enhances survival of cardiomyocytes and induces regeneration of myocardium after myocardial infarction. Circulation 2003, 108:748-753.